Your shopping cart is currently empty

LT052 is a selective and efficient BET BD1 inhibitor with anti-inflammatory activity. It mediates the BRD4/NF-κB/NLRP3 inflammatory signaling pathway and can be used in gout arthritis research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $34 | - | In Stock |
| Description | LT052 is a selective and efficient BET BD1 inhibitor with anti-inflammatory activity. It mediates the BRD4/NF-κB/NLRP3 inflammatory signaling pathway and can be used in gout arthritis research. |
| Targets&IC50 | BRD3 BD1:246.3 nM, BRPF1b:567.5 nM, BRDT BD1:357.1 nM, BRD4 BD1:87.7 nM |
| In vitro | LT052 (1 μm,1h) inhibited MSU-induced apoptosis of THP-1 cells through the BRD4/NF-κB/NLRP3 signaling pathway. LT052 showed good inhibitory activity on NO production in RAW264.7 cells. LT052 inhibits NF-κB transcriptional activity in HUVECs. LT052 inhibits scorch death of macrophages in rat synovial tissue by regulating the BRD4/NF-κB/NLRP3 signaling pathway. [1] |
| In vivo | LT052 has a high clearance rate in the range of 93.517 µL/min/mg proteins to 146.685 µL/min/mg proteins in liver microsomes of multiple species (human, monkey, dog, rat). Overall, LT052 exhibits moderately stable levels of in vitro liver microsomal metabolism[1]. LT052 (1 mg/kg; intra-articular) suppresses synovial hyperplasia as well as severe neutrophil infiltration, and has a good therapeutic effect on MSU-induced acute gouty arthritis[1]. |
| Synonyms | LT 052 |
| Molecular Weight | 449.48 |
| Formula | C22H19N5O4S |
| Cas No. | 2543545-44-2 |
| Smiles | O=C1C2=CC(=NC3=C(C=CC(=C32)N1C)NS(=O)(=O)C=4C=CC=CC4OC)N5C=NC(=C5)C |
| Relative Density. | 1.49 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 5 mg/mL (11.12 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.